CompletedPhase 2NCT01302795
Canakinumab for Pyoderma Gangrenosum
Studying Pyoderma gangrenosum
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Zurich
- Principal Investigator
- Lars French, Prof MD, MDUniversity Hospital Zurich, Division of Dermatology
- Intervention
- Canakinumab(drug)
- Enrollment
- 5 enrolled
- Eligibility
- 18-99 years · All sexes
- Timeline
- 2011 – 2015
Study locations (1)
- Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01302795 on ClinicalTrials.gov